Exclusive: Governor DeSantis Files Motion in Opposition to Oral Argument in Sansone V. DeSantis mRNA Bioweapons Case

Key Takeaways

• DeSantis filed a boiler‑plate response opposing oral argument
• Sansone claims mRNA shots are bioweapons harming 23 million Floridians
• Oral argument is discretionary; denial doesn’t predict case outcome
• Prior appeals dismissed; procedural win keeps case alive
• Case includes expert affidavits linking mRNA to health‑freedom violations

Pulse Analysis

The Sansone v. DeSantis lawsuit has thrust Florida’s COVID‑19 vaccine policy into a courtroom drama that few expected. Dr. Joseph Sansone, a psychotherapist representing himself, alleges that the state’s endorsement of mRNA vaccines amounts to the distribution of biological weapons, citing personal health complications and a broader threat to the state’s 23 million residents. His complaint, filed in December 2024, amassed a voluminous record of expert affidavits, ranging from legal scholars who helped draft the 1989 Biological Weapons Act to physicians who label mRNA technology as hazardous. While the claims are extraordinary, the case has survived multiple procedural hurdles, including a dismissal and a subsequent appeal win on November 12, 2025.

The latest development is Governor Ron DeSantis’s and Attorney General Ashley Moody’s response to Sansone’s motion for oral argument, filed on April 1, 2026. The response, described as boiler‑plate, argues that oral argument is not a guaranteed right and should only be granted if the court deems it essential for resolving the appeal. This procedural stance underscores the court’s discretion: a denial of oral argument does not signal how the judges will rule on the substantive allegations. For litigants, the decision whether to grant oral argument can influence the depth of judicial scrutiny and the public visibility of the case, especially given the First District Court of Appeal’s practice of live‑streaming arguments.

Beyond the immediate parties, the case reflects a broader clash between public‑health initiatives and a growing segment of the population that frames vaccines as threats to personal liberty and safety. If the appellate court permits oral argument, the live‑stream could amplify the controversy, potentially shaping public opinion and prompting legislative scrutiny of vaccine mandates. Conversely, a denial may keep the dispute confined to written briefs, limiting its impact but leaving the substantive question—whether mRNA vaccines can be legally classified as bioweapons—unresolved. Either outcome will be watched closely by policymakers, health officials, and advocacy groups monitoring the balance between state‑directed health measures and individual rights.